A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain

  1. Macía, M.
  2. Díaz-Encarnación, M.
  3. Solans-Laqué, R.
  4. Mallol, E.P.
  5. Castells, A.G.
  6. Escribano, C.
  7. de Arellano, A.R.
Journal:
Expert Review of Pharmacoeconomics and Outcomes Research

ISSN: 1744-8379,  1473-7167

Year of publication: 2024

Volume: 24

Issue: 2

Pages: 227-235

Type: Article

DOI: 10.1080/14737167.2023.2297790 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus